Hancock valves have been placed in 605 patients. One hundred seventy-five patients with a mitral xenograft have been restudied. The results were questionable due to the wide scatter and disparity between the calculated and the theoretical orifice of each valve size. To elucidate these differences, the hemodynamic data of 40 isolated, normal functioning mitral Hancock valves were reviewed. Early, middle and late diastolic mitral valve gradients were measured by planimetry and their corresponding flows were estimated by angiography. The paired data were fitted to exponential functions and specific lines for each Hancock valve size were obtained. By superimposing Gorlin's pressure and flow curves on these lines, the instantaneous effective orifice for each Hancock valve can be determined. We concluded that 1) the Hancock valve effective orifice is flow related and always lower than its theoretical opening; 2) normal function frequently cannot be firmly established by the mean effective area; and 3) the nomogram described may help in determining the time-related variations of a particular valve.
GLUTARALDEHYDE porcine heterografts are being used clinically in increasing numbers for valve replacement. Several studies on the postoperative hemodynamics of these valves have been published,'-8 and similarities to the hemodynamics of mechanical prostheses have been found." 3' 4 At our institution, 305 Hancock valves have been studied hemodynamically, and the findings agree with those of other investigators. One hundred seventy-five patients with Hancock valves in the mitral position were recatheterized, and we were surprised by the disparity between the effective hemodynamic area of a particular valve and its theoretical orifice. This disparity, also noted by Hannah,3 Johnson5 and Lurie,6 could, in principle, result from a difference in the physical orifices for the same size prosthesis due to variability in manual construction,9 or from the peculiar behavior of the bioprosthesis, which varies its opening in response to the continuous changes of flow and gradient during diastole. The latter hypothesis, recently demonstrated in vitro,'0-13 needed confirmation in vivo. Furthermore, if widely different calculated effective orifices can be obtained with a particular valve and related to variations in flow or pressure, it may be difficult or impossible to establish by hemodynamic studies whether the prosthesis is functioning properly or not.
In an attempt to solve this problem, we have reanalyzed the hemodynamic factors that might determine this disparity and have developed specific From the Seccion de Hemodinamica, the Servicio de Cardiologia, and the Servicio Cardiovascular, Centro Medico Nacional "Valdecilla," Universidad de Santander, Santander, Spain.
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Methods
From June 1974 to December 1978, 175 patients with a mitral Hancock xenograft were restudied at our institution 3-18 months postoperatively (average 6.3 months). For this study, 40 patients with Hancock valves model 342, A-V, were selected according to the following criteria: 1) apparently normal function based on the absence of clinical regurgitation and bacterial endocarditis; 2) no angiographic regurgitation or atrial thrombi; and 3) adequate quality of the angiographic and hemodynamic data. Ten patients were male and 30 were female, ages 28-60 years (mean 45 years). Thirty-six were in atrial fibrillation and four were in sinus rhythm. Thirty-four had isolated mitral replacements and six had simultaneous tricuspid surgery. Aortic valve disease was not present in any of the patients. The Hancock valves ranged in size from 23-33 mm.
The patients were premedicated with diazepam (10 mg i.m.) 30 minutes before catheterization. A percutaneous femoral access was used with Seldinger technique in every patient. In all cases, standard right and left catheterization was performed with #7 or #8 Cournand and Millar microtip ventricular catheters. Pressures were measured at midthoracic points. The wedge pressure tracings were obtained with Hewlett-Packard 1280 transducers with a damping coefficient of 0.66 and recorded at 100 mm/sec with Hewlett-Packard amplifiers and recorder. During the contrast injection, high-quality pulmonary wedge and left ventricular pressures were simultaneously recorded. The wedge pressure was considered valid only if 1) completely saturated blood (> 95%) could be aspirated from the catheter; 2) systolic pulmonary artery pressure was less than 50 mm Hg; 3) clearly visible "a" and/or "c" waves were present; and 4) obvious respiratory oscillations were observed. Left ven-tricular cineangiograms were taken in the 300 right anterior oblique projection. In each patient, 0.5-1 ml/kg of 82% meglumine metrizoate* was injected in 2 seconds. Filming was carried out using 35-mm Valca F 22 film and a Camaflex G.V. 35 camerat at a speed of 100 images/sec through a Hyperlux amplifier.t The ECG was simultaneously recorded on the film with a Corgraph.t X-ray magnification was corrected by relating the catheter diameter to its radiographic diameter. At the moment of contrast injection, a blank frame appeared on the film and simultaneously a vertical marker was printed every 1/100 second in the pressure tracing. Therefore the angiographic image could be related with the pressure event.
In order to correct the time delay between the pulmonary wedge and the left atrial pressure, the wedge tracing was moved forward until the "c" wave coincided with the upswing of the left ventricular pressure tracing ( fig. 1 ).
The atrioventricular emptying period was defined as the diastolic time minus the systolic and diastolic isometric phases and calculated as the interval between the crossing of the ventricular and atrial curves. This emptying period was divided into three equal parts: early, middle and late diastole ( fig. 2A ). The gradient was calculated for each part by dividing the corresponding areas, measured by planimetry (Aristo Werke 1 130 L), by the time interval. The partial gradients were expressed as mm Hg. The mitral valve gradient was calculated as: area (cm2) diastolic filling period (cm)
X> lO(mm Hg)
To select, in the angiogram, the first frame of mitral opening corresponding to the pressure tracing selected for study, the same number of markers in the tracing was counted as frames in the cine from the first blank frame (1 msec = 1 cine frame). The partial left ven-*Angiocontrast 440, Juste S.A., Madrid.
tCompagnie Generale Radiologie, Paris. tricular filling volumes that corresponded to each early, middle and late diastolic period were calculated using a Vanguard motion analyzer with Hewlett-Packard 5693 analyzer and computer system (model 5690 B standard). Each volume was obtained by subtracting the previous volume ( fig. 2B ). The partial diastolic flows were calculated in milliliters divided by their corresponding time intervals in seconds. All calculations were done by a single observer. The effective orifice of the Hancock valve in each diastolic period was calculated with the formula of Gorlin and Gorlin.14 The empirical constant of 38 was used because a direct measurement of the left ventricular diastolic pressure was available.'5 Gorlin's hydraulic formula can be used to calculate any orifice area provided its discharge coefficient is known. This coefficient varies with the type of orifice and flow characteristics, as shown specifically for the xenografts by Wright. 16 We used this coefficient because most laboratories use it and because of the small difference between the 0.88 of the hydraulic formula and 1.06 of the xenograft Hancock valves.
The mean values and standard deviations of the early, middle and late diastolic flows and gradients of all patients were plotted together ( fig. 3 ). These data were placed on Gorlin pressure and flow curves (k = 38).
The early, middle, late and mean diastolic flows and their corresponding calculated effective orifices were plotted together for all patients with the same Hancock valve size. A relationship between flows and orifices was observed, with larger areas corresponding to larger flows and vice versa; this diagram tended to be a curve. We assumed that at some point a maximal effective orifice must be reached that cannot increase however high the flow. The curve should, at that point, become parallel to the flow axis. We therefore applied an exponential function using the 4 ). When the gradients corresponding to each flow were calculated from this curve, a new flow-gradient curve was constructed. By superimposing our flow and gradient data, high correlation coefficients were also obtained. When Gorlin pressureflow curves were superimposed, a graph was constructed that related flows, gradients and areas for each Hancock valve size ( fig. 5 ).
Results
The hemodynamic data from the 40 patients selected for this study are presented in table 1. The calculated mitral valve orifice area for the group averaged 2.02 ± 0.46 cm2 (range 1.22-2.93 cm2). Although the average calculated orifice areas increase with the size of the bioprosthesis, a large dispersion exists for the same prosthetic size ( fig. 6 ). The average early diastolic calculated area for the whole group was 2.52 ± 0.67 cm2. The mid-diastolic area was 2.0 ± 0.52 cm2 and the late diastolic area was 1.33 ± 0.52 cm2. The average calculated diastolic flow for the group was 266 ± 70 ml/sec. The early diastolic flow was 390 ± 109 ml/sec. The mid-diastolic flow was 271 ± 86 ml/sec, and the end-diastolic flow was 136 ± 69 ml/sec. The average mitral valve gradient for the whole group was 12.3 ± 4.5 mm Hg. The early diastolic gradient was 17.1 ± 5.5 mm Hg, the middiastolic gradient was 12.7 ± 5.3 mm Hg and the end-diastolic gradient was 7.2 ± 4.0 mm Hg. These data show a continuous decrease in the gradient and flow during the atrial emptying period. The four patients in sinus rhythm were not hemodynamically different from those in atrial fibrillation. The mean, standard deviation and standard error of the mean of the mitral gradient, flow and area for each Hancock valve size are presented in table 2.
When the average early, middle and late diastolic flows are plotted against their corresponding mitral gradients and superimposed on Gorlin's pressure-flow curves, it can be observed that the effective orifice decreases as flow and pressure gradient decrease from early to late diastole ( fig. 3 ). When the early, middle, late and mean diastole flows and gradients are plotted for each patient with the same size xenograft, exponential curves with high correlation coefficients result ( fig. 5 ). Each valve size is represented by a particular curve, all of which cross the fixed-orifice Gorlin pressure-flow curves, indicating a variability in the effective orifice of the Hancock valve. Therefore, all of the Hancock valve effective areas increase in response to rises in flow and pressure gradient. At low flow, below 200 ml/sec, the large bioprostheses have satisfactory openings with small gradients. The 23and 25-mm valves in this situation are already relatively stenotic, with openings less than 2 cm2. These differences increase progressively with higher flows. The small Hancock sizes are limited and need pathologically high gradients to achieve flows greater than 300 ml/sec. The effective areas of the larger bioprostheses can increase progressively up to 4 cm2. 0 100 When the partial flows of all patients with a similar Hancock size are plotted against their respective early, middle and late diastolic calculated effective orifices, size-related curves result. These curves mathematically define the behavior of the Hancock valve in relation to the flow that crosses them ( fig. 4 ).
Discussion
Since the early clinical use of the mitral xenografts it has been stated that, hemodynamically speaking, they function correctly and that their central flow characteristics are an advantage over other types of mitral prostheses. Several authors have reported their hemodynamic results by showing the mean diastolic gradients and mean effective areas.'-" When all results were grouped by the Hancock valve size, a large scattering of data appeared.3' 5" Some patients had large areas and some small with the same prosthetic size, and even large valves could have smaller areas than those found in small prostheses. In our early studies, we found the same scatter of results.' Because the in vitro studies of Wright'6 have shown a manufacturer's maximum orifice variability of 10%, this different behavior of the same size prosthesis can only be due to changing hemodynamic factors that determine different effective orifices for the same valve.
A group of 40 patients was selected among our 175 recatheterized mitral patients, based on the quality of the hemodynamic and angiographic data and lack of associated aortic pathology that might give unreliable left ventricular volumes. We considered that a pulmonary wedge pressure could be substituted for left atrial pressure if a time correction was introduced, as shown by Hammermeister et al.'7 However, instead of using a 0.08 correcting factor, which ignores individual changes at the time of the study, the time delay was corrected in each case by moving the wedge tracing forward until the "c" wave crossed the upstroke of the left ventricular pressure tracing. A single observer calculated all left ventricular volumes.
The accuracy in the measurement of the mitral gradients at a relatively small gain should not be a problem in the first and middle thirds of diastole. In late diastole, a loss of accuracy is possible, due to the small size of the gradients. However, because the calculated area is inversely proportional to the square root of the gradient, this small figure would only influence the exponential curves at their lowest flows, where all are close together and sometimes overlap, as shown in vitro. 16 Moreover, our patients, however low their cardiac output, did not fall within this area of the curves.
Although most investigators have used 31 as the empirical constant for calculating Gorlin's formula, we consider an empirical constant of 38 more appropriate when left-heart data are used. In this study, we determined the exact flow, gradient and, therefore, area during each third of diastole. The arithmetic mean of these data gives the mean flows, gradients and areas of each valve. These mean values are similar to those already found by others and ourselves. The discrepancy between the results in different patients with the same size valve is due to the flow crossing the valve at the time of the study. A valve has progressively smaller areas in early, middle and late diastole, which relates to the progressive decrease in mitral flow during the atrioventricular emptying ( fig. 3 ). Theoretically, patients in sinus rhythm should increase their flow in late diastole, during active atrial systole. However, the four patients in sinus rhythm had no increase in late diastolic flow or late diastolic area, probably due to reduced atrial contractility.
If we apply Gorlin's formula, which relates flow and gradient, to the Hancock valve, we note that this ratio is not constant and that it decreases as flow decreases due to the progressive reduction in the effective valve orifice. In figure 5 it can be seen how the curve for a particular Hancock valve crosses the Gorlin pressureflow curve. For instance, a Hancock 31-mm valve has an area of 1.4 cm' at 150 ml/sec with a 7-mm Hg gradient. This same valve at flows of 350 ml/sec has an area of 2.7 cm2 and a gradient of 12 mm Hg. If this Hancock 3 1-mm valve had a constant area of 1.5 cm', it would require a 38-mm Hg gradient to achieve a flow of 350 ml/sec. Large Hancock valves adapt well to high mitral flows, achieving areas of up to 4 cm2. These large areas are only obtained in early diastole, when the flow is at its maximum, and are far larger than the mean areas for all diastole.-Smaller valves (23-and 25-mm) never achieve areas larger than 1.8 cm2 and therefore cannot attain flows higher than 380 ml/sec because they would need nonphysiologic 391 39LCRCLAIN VOL 61, No 2, FEBRUARY 1980 20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40   Rhythm  AF  AF  AF  AF  AF  AF  AF  AF  AF  AF  AF  AF  SR  AF  AF  AF  AF  AF  SR  AF  AF  SR  AF  AF  AF  AF  AF  SR  AF  AF  AF  AF  AF  AF  AF  AF  AF  AF  AF (mm)   500  683  428  500  307  340  471  358  375  313  685  346  354  666  430  380  218  445  371  533  388  300  250  300  430  315  390  330  450  250   433  457  320  380  341  311  363  345  266  310   390  109   17   362  433  107  385  300  240  300  133  208  200  442  161  181  450  260  300  200  272  271  300  377  330  210  237  169  192  250  223  275  230  360  442  200  260  300  164  300  263  260  290   271  86  13   75  130  46  228  146  150  150  100  125  46  128  130   136  100  90  110  136  127  214  222  255  270  130  150  53  61  110  38  162  80  300  285   110   70  166   0   218  136  180  100   136  69   11   312  408  197  371  251  243  304  197  253  186  419  212  224  405  260  263  184  281  285  351  340  300  196  229  218  189  250  197  295  186  364  395  210  236  269  158  293  248  235  233   266 .T. 0 tanned leaflets, and is probably common to other types of porcine xenografts, distinguishing them hemodynamically from mechanical prostheses. The nomogram described here allows one to calculate the effective opening achieved for each Hancock valve size at different flows. Only this method can determine whether a particular Hancock valve is functioning correctly in a particular patient. This method will probably allow us to follow the natural history of this prosthesis, because if there is a progressive resistance to its opening (e.g., calcification) a shift to the left in the nomogram will appear. gradients. All curves eventually become parallel to the Gorlin lines, which indicates that the valve has achieved its maximal physical orifice and, therefore, changes from a variable to a fixed orifice ( fig. 5 ). The reported variability in effective area in the mitral Hancock valve is due to the fact that each patient had a different flow at the time of the study and therefore had a calculated valve opening relating to the flow. Our results seem to corroborate clinically those found in vitro by Thomson, 12 who showed, in the pulse duplicator, that openings changed with flow variations. Wright9 also studied the hydrodynamic performance of the Hancock valve in vitro, and showed that this valve behaves as an orifice of variable area, with larger openings at higher flows. Although the Hancock valve areas are also gradient-dependent, we use flow as the determining factor because these in vitro studies use this variable. This flow-related characteristic of the Hancock valve is probably due to increased resistance to flow secondary to the presence of the muscle shelf and the rigidity of the glutaraldehyde 
